← SynDRA
nemonapride
SynDRA canonical compound SYN0041615 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | DRD3 |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- DRD3
- DRD4
- Adra1a
- Drd2
- Drd3
- Htr2a
- TMEM97
Mechanisms of action (all sources)
- Dopamine receptor antagonist
Drug classes
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Dopamine Agents
- Dopamine Antagonists
- Neurotransmitter Agents
- Psychotropic Drugs
- Tranquilizing Agents
Cross-references
Synonyms
- emonapride
- Emonapride
- Emilace
- [3H]nemonapride
- (+)-nemonapride
- (2R,3R)-nemonapride
- N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide
- CHEBI:64219
- Q88T5P3444
- N-(Cis-1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
- Nemonapride [INN:JAN]
- YM-09151
- UNII-Q88T5P3444
- Emilace (TN)
- YM-09151-2
- Nemonapride (JAN/INN)
- NEMONAPRIDE [MI]
- NEMONAPRIDE [INN]
- NEMONAPRIDE [JAN]
- (+-)-cis-N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide
- (+-)-cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide
- N-(2RS,3RS)-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide
- NEMONAPRIDE [MART.]
- GTPL962
- NEMONAPRIDE [WHO-DD]
- SCHEMBL1649724
- DTXSID601116422
- ZINC538069
- BDBM50487259
- PDSP1_001527
- PDSP2_001511
- NCGC00371107-01
- Benzamide, 5-chloro-2-methoxy-4-(methylamino)-N-((2R,3R)-2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)-, rel-
- Benzamide, 5-chloro-2-methoxy-4-(methylamino)-N-(2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)-, cis-(+-)-
- HY-103415
- CS-0027847
- D01468
- BRD-K47289124-001-02-6
- (+/-)-cis-N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide
Look up nemonapride in the interactive SynDRA portal →